Increasing incidence of invasive group A streptococcus disease in New Zealand, 2002-2012: A national population-based study

Journal of Infection

Volumn 70, Issue 2, 2015, Pages 127-134

  Williamson, Deborah A ^a,b   Morgan, Julie ^a   Hope, Virginia ^a   Fraser, John D ^b   Moreland, Nicole J ^b   Proft, Thomas ^b   Mackereth, Graham ^a   Lennon, Diana ^a   Baker, Michael G ^c   Carter, Philip E ^a  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Epidemiology; Sepsis; Streptococcal disease

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHILD; DEMOGRAPHY; DISEASE SURVEILLANCE; EMM GENE; EMM1 GENE; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MORTALITY; NEW ZEALAND; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; SEQUENCE ANALYSIS; TREND STUDY; YOUNG ADULT; CROSS-SECTIONAL STUDY; INCIDENCE; MICROBIOLOGY; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; NEW ZEALAND; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 84921057413     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.09.001     Document Type: Article

References (33)

1. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5(11):685-694.
2. Ralph A.P., Carapetis J.R. Group A streptococcal diseases and their global burden. Curr Top Microbiol Immunol 2013, 368:1-27.
3. Steer A.C., Lamagni T., Curtis N., Carapetis J.R. Invasive group Astreptococcal disease: epidemiology, pathogenesis and management. Drugs 2012, 72(9):1213-1227.
4. Milne R.J., Lennon D., Stewart J.M., Vander Hoorn S., Scuffham P.A. Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand. J Paediatr Child Health 2012, 48(8):692-697.
5. Wong W., Lennon D.R., Crone S., Neutze J.M., Reed P.W. Prospective population-based study on the burden of disease from post-streptococcal glomerulonephritis of hospitalised children in New Zealand: epidemiology, clinical features and complications. J Paediatr Child Health 2013, 49:850-855.
6. Stockmann C., Ampofo K., Hersh A.L., Blaschke A.J., Kendall B.A., Korgenski K., et al. Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis 2012, 55(4):479-487.
7. O'Loughlin R.E., Roberson A., Cieslak P.R., Lynfield R., Gershman K., Craig A., et al. Active Bacterial Core Surveillance Team: The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007, 45(7):853-862.
8. Darenberg J., Luca-Harari B., Jasir A., Sandgren A., Pettersson H., Schalen C., et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007, 45(4):450-458.
9. Lepoutre A., Doloy A., Bidet P., Leblond A., Perrocheau A., Bingen E., et al. Microbiologists of the Epibac Network: Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol 2011, 49(12):4094-4100.
10. Plainvert C., Doloy A., Loubinoux J., Lepoutre A., Collobert G., Touak G., et al. CNR-Strep network: Invasive group A streptococcal infections in adults, France (2006-2010). Clin Microbiol Infect 2012, 18(7):702-710.
11. Safar A., Lennon D., Stewart J., Trenholme A., Drinkovic D., Peat B., et al. Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. Emerg Infect Dis 2011, 17(6):983-989.
12. Beall B., Facklam R., Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996, 34(4):953-958.
13. Smeesters P.R., McMillan D.J., Sriprakash K.S. The streptococcal M protein: a highly versatile molecule. Trends Microbiol 2010, 18(6):275-282.
14. McNeil S.A., Halperin S.A., Langley J.M., Smith B., Warren A., Sharratt G.P., et al. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005, 41(8):1114-1122.
15. Dale J.B., Penfound T.A., Tamboura B., Sow S.O., Nataro J.P., Tapia M., et al. Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine 2013, 31(12):1576-1581.
16. Dale J.B., Penfound T.A., Tamboura B., et al. Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine 2013, 31(12):1576-1581.
17. Steer A.C., Law I., Matatolu L., Beall B.W., Carapetis J.R. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009, 9(10):611-616.
18. Salmond C., Crampton P., Sutton F. NZDep91: a New Zealand index of deprivation. Aust N Z J Public Health 1998, 22(7):835-837.
19. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007 Oct 17, 298(15):1763-1771.
20. Grundmann H., Hori S., Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 2001, 39(11):4190-4192.
21. Williamson D.A., Lim A., Thomas M.G., Baker M.G., Roberts S.A., Fraser J.D., et al. Incidence, trends and demographics of Staphylococcus aureus infections in Auckland, New Zealand, 2001-2011. BMC Infect Dis 2013, 13(1):569.
22. Baker M.G., Barnard L.T., Kvalsvig A., Verrall A., Zhang J., Keall M., et al. Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study. Lancet 2012, 379(9821):1112-1119.
23. Zakikhany K., Degail M.A., Lamagni T., Waight P., Guy R., Zhao H., et al. Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveill 2011, 16(5):19785.
24. Siljander T., Lyytikainen O., Vahakuopus S., Snellman M., Jalava J., Vuopio J. Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland. Eur J Clin Microbiol Infect Dis 2010, 29(10):1229-1235.
25. O'Sullivan C.E., Baker M.G., Zhang J. Increasing hospitalizations for serious skin infections in New Zealand children, 1990-2007. Epidemiol Infect 2011, 139(11):1794-1804.
26. Williamson D.A., Ritchie S.R., Lennon D., et al. Increasing incidence and sociodemographic variation in community-onset Staphylococcus aureus skin and soft tissue infections in New Zealand children. Pediatr Infect Dis J 2013 Aug, 32(8):923-925.
27. Das D.K., Baker M.G., Venugopal K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J Infect 2011, 63(6):429-433.
28. Factor S.H., Levine O.S., Schwartz B., Harrison L.H., Farley M.M., McGeer A., et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003, 9(8):970-977.
29. Coppell K.J., Mann J.I., Williams S.M., Jo E., Drury P.L., Miller J.C., et al. Prevalence of diagnosed and undiagnosed diabetes and prediabetes in New Zealand: findings from the 2008/09 Adult Nutrition Survey. N Z Med J 2013, 126(1370):23-42.
30. Luca-Harari B., Ekelund K., van der Linden M., Staum-Kaltoft M., Hammerum A.M., Jasir A. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 2008, 46(1):79-86.
31. Wahl R.U., Lutticken R., Stanzel S., van der Linden M., Reinert R.R. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system. Clin Microbiol Infect 2007, 13(12):1173-1178.
32. Williamson D.A., Moreland N.J., Carter P.E., Upton A., Morgan J., Proft T., et al. Molecular epidemiology of group A streptococcus from pharyngeal isolates in Auckland, New Zealand, 2013. NZMed J 2014, 127:1388.
33. Bedford R., Hugo G. Population Movement in the Pacific: APerspective on Future Prospects 2012, Department of Labour Report, Wellington, New Zealand, Available online:. http://www.dol.govt.nz/publications/research/population-movement-pacific-perspective-future-prospects/report.pdf.